(Q36546561)

14 August 2017

A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia (English)

1 reference

14 August 2017

2

Melina R Kibbe

1 reference

14 August 2017

Douglas W Losordo

1

1 reference

14 August 2017

Farrell Mendelsohn

3

1 reference

14 August 2017

William Marston

4

1 reference

14 August 2017

Vickie R Driver

5

1 reference

14 August 2017

Melhem Sharafuddin

6

1 reference

14 August 2017

Victoria Teodorescu

7

1 reference

14 August 2017

Bret N Wiechmann

8

1 reference

14 August 2017

Charles Thompson

9

1 reference

14 August 2017

Larry Kraiss

10

1 reference

14 August 2017

Teresa Carman

11

1 reference

14 August 2017

Suhail Dohad

12

1 reference

14 August 2017

Paul Huang

13

1 reference

14 August 2017

Candice E Junge

14

1 reference

14 August 2017

Kenneth Story

15

1 reference

14 August 2017

Tara Weistroffer

16

1 reference

14 August 2017

Tina M Thorne

17

1 reference

14 August 2017

Meredith Millay

18

1 reference

14 August 2017

John Paul Runyon

19

1 reference

14 August 2017

Robert Schainfeld

20

1 reference

14 August 2017

Autologous CD34+ Cell Therapy for Critical Limb Ischemia Investigators

21

1 reference

14 August 2017

27 November 2012

1 reference

Circulation: Cardiovascular Interventions

14 August 2017

1 reference

14 August 2017

5

1 reference

14 August 2017

6

1 reference

14 August 2017

821-830

1 reference

Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Update on biological therapies for critical limb ischemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Treatment of peripheral arterial disease using stem and progenitor cell therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

The prevalence of peripheral arterial disease in a defined population

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3549397

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

21 September 2018

1 reference

12 December 2020

Angiogenesis for revascularization of ischaemic tissues

1 reference

12 December 2020

Therapeutic angiogenesis in ischemic limbs

1 reference

12 December 2020

Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia

1 reference

12 December 2020

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial

1 reference

12 December 2020

Second European Consensus Document on chronic critical leg ischemia

1 reference

12 December 2020

10.1161/CIRCINTERVENTIONS.112.968321

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23192920

1 reference